Nutritional composition for children with reflux, colic and/or constipation

Abstract

The present invention is directed to an infant formula specially designed to reduce episodes of regurgitation, colic and constipation that occur in infants fed on infant formula. The composition represents a needed improvement to the art because it contains in a single composition substances that simultaneously addresses these three problems.

1 - 27 . (canceled) 
     
     
         28 . An infant formula composition comprising, in 100 grams of dry powder, about 12.8 grams of protein, about 58 grams of carbohydrate, and about 23.8 grams of lipid, wherein the carbohydrate comprises about 14.5 grams potato starch, the protein comprises alpha lactalbumin and beta casein, wherein the content of alpha lactalbumin is from about 16% to 25% based on the total protein of the composition, and wherein the beta casein comprises beta casein A2 and beta casein A1 at a ratio of from about 50:50 to 100:0, and the lipid comprises about 1.8 grams beta palmitic acid. 
     
     
         29 . The infant formula composition of  claim 28 , wherein the content of alpha lactalbumin is about 18% based on the total protein, and wherein all the beta casein is beta casein A2. 
     
     
         30 . The infant formula composition of  claim 28  wherein the carbohydrate further comprises lactose, maltodextrin, or a combination thereof. 
     
     
         31 . The infant formula composition of  claim 28  further comprising at least one component selected from the group consisting of corn starch, xanthan gum, locust bean gum, carboxymethylcellulose, non-digestible oligosaccharide, long chain polyunsaturated fatty acid, nucleotide, vitamin, mineral, inositol, choline, taurine, and carnitine. 
     
     
         32 . The infant formula composition of  claim 31 , wherein the nucleotide comprises AMP, CMP, GMP, IMP, UMP, or a combination thereof at the following concentration: from 1 mg to 15 mg AMP; from 5 to 30 mg CMP; from 1 mg to 10 mg GMP; from 1 mg to 10 mg IMP; and from 1 mg to 15 mg UMP. 
     
     
         33 . The infant formula composition of  claim 32 , wherein the total amount of the nucleotide or a combination thereof in the composition is 24.1 mg. 
     
     
         34 . The infant formula composition of  claim 31 , wherein the long chain polyunsaturated fatty acid comprises from about 60 mg to 100 mg DHA, from about 100 mg to about 200 mg ARA, or a combination thereof. 
     
     
         35 . The infant formula composition of  claim 31 , wherein the non-digestible oligosaccharide is selected from the group consisting of fructooligosaccharide, galactooligosaccharide, and a combination thereof. 
     
     
         36 . The infant formula composition of  claim 31 , wherein the vitamins and minerals are selected from the group consisting of sodium, potassium, calcium, phosphorus, chlorine, magnesium, manganese, iron, copper, zinc, selenium, iodine, vitamin A, C, D, E, K, vitamin B1, vitamin B2, vitamin B6, vitamin B12, niacin, pantothenic acid, and a combination thereof. 
     
     
         37 . The infant formula composition of  claim 31 , wherein the inositol is from about 10 mg to about 100 mg, the choline is from about 10 to about 100 mg, the taurine is from about 10 mg to about 100 mg, and the carnitine is from about 1 mg to about 50 mg. 
     
     
         38 . A reconstituted infant formula comprising 14.5 grams of the infant formula of  claim 28  and water to a final volume of 100 ml.